As of 2025-03-17, the Relative Valuation of Avid Bioservices Inc (CDMO) is (63.77) USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.49 USD, the upside of Avid Bioservices Inc based on Relative Valuation is -610.6%.
The range of the Relative Valuation is (39.11) - (81.79) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.5x - 41.2x | 28.8x |
| Forward P/E multiples | 15.4x - 34.5x | 25.0x |
| Fair Price | (39.11) - (81.79) | (63.77) |
| Upside | -413.2% - -754.8% | -610.6% |
| Date | P/E |
| 2025-02-06 | -5.27 |
| 2025-02-05 | -5.27 |
| 2025-02-04 | -5.27 |
| 2025-02-03 | -5.26 |
| 2025-01-31 | -5.26 |
| 2025-01-30 | -5.26 |
| 2025-01-29 | -5.25 |
| 2025-01-28 | -5.24 |
| 2025-01-27 | -5.25 |
| 2025-01-24 | -5.24 |
| 2025-01-23 | -5.25 |
| 2025-01-22 | -5.25 |
| 2025-01-21 | -5.26 |
| 2025-01-17 | -5.23 |
| 2025-01-16 | -5.22 |
| 2025-01-15 | -5.23 |
| 2025-01-14 | -5.24 |
| 2025-01-13 | -5.24 |
| 2025-01-10 | -5.23 |
| 2025-01-08 | -5.22 |
| 2025-01-07 | -5.21 |
| 2025-01-06 | -5.21 |
| 2025-01-03 | -5.20 |
| 2025-01-02 | -5.20 |
| 2024-12-31 | -5.21 |
| 2024-12-30 | -5.20 |
| 2024-12-27 | -5.16 |
| 2024-12-26 | -5.18 |
| 2024-12-24 | -5.17 |
| 2024-12-23 | -5.18 |
| 2024-12-20 | -5.19 |
| 2024-12-19 | -5.20 |
| 2024-12-18 | -5.19 |
| 2024-12-17 | -5.21 |